Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 643

1.

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.

Mitchell DA, Batich KA, Gunn MD, Huang MN, Sanchez-Perez L, Nair SK, Congdon KL, Reap EA, Archer GE, Desjardins A, Friedman AH, Friedman HS, Herndon JE 2nd, Coan A, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, Sampson JH.

Nature. 2015 Mar 19;519(7543):366-9. doi: 10.1038/nature14320. Epub 2015 Mar 11.

PMID:
25762141
2.
3.

Prognostic marker analysis in pediatric intracranial ependymomas.

McLendon RE, Lipp E, Satterfield D, Ehinger M, Austin A, Fleming D, Perkinson K, Lefaivre M, Zagzag D, Wiener B, Gururangan S, Fuchs H, Friedman HS, Herndon JE 2nd, Healy P.

J Neurooncol. 2015 Apr;122(2):255-61. doi: 10.1007/s11060-014-1711-z. Epub 2015 Jan 7.

PMID:
25563815
4.

Frequency of high-risk patients not receiving high-potency statin (from a large managed care database).

Rodriguez F, Olufade T, Heithoff K, Friedman HS, Navaratnam P, Foody JM.

Am J Cardiol. 2015 Jan 15;115(2):190-5. doi: 10.1016/j.amjcard.2014.10.021. Epub 2014 Oct 30.

PMID:
25432414
5.

Severe Adverse Immunologic Reaction in a Patient with Glioblastoma Receiving Autologous Dendritic Cell Vaccines Combined with GM-CSF and Dose-Intensified Temozolomide.

Mitchell DA, Sayour EJ, Reap E, Schmittling R, DeLeon G, Norberg P, Desjardins A, Friedman AH, Friedman HS, Archer G, Sampson JH.

Cancer Immunol Res. 2015 Apr;3(4):320-5. doi: 10.1158/2326-6066.CIR-14-0100. Epub 2014 Nov 11.

PMID:
25387895
6.

Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models.

Di K, Keir ST, Alexandru-Abrams D, Gong X, Nguyen H, Friedman HS, Bota DA.

J Neurooncol. 2014 Dec;120(3):473-81. doi: 10.1007/s11060-014-1579-y. Epub 2014 Aug 13.

PMID:
25115740
7.

Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients.

Peters KB, West MJ, Hornsby WE, Waner E, Coan AD, McSherry F, Herndon JE 2nd, Friedman HS, Desjardins A, Jones LW.

J Neurooncol. 2014 Dec;120(3):499-506. doi: 10.1007/s11060-014-1574-3. Epub 2014 Aug 13.

PMID:
25115739
8.

Bevacizumab therapy for glioblastoma: a passionate discussion.

Desjardins A, Friedman HS.

CNS Oncol. 2014 Jan;3(1):1-3. doi: 10.2217/cns.13.53. No abstract available.

9.

Revolutionary health psychology versus scientific health psychology - commentary on Murray (2012).

Friedman HS.

Health Psychol Rev. 2014;8(2):238-41. doi: 10.1080/17437199.2013.770048. Epub 2013 Feb 21. No abstract available.

PMID:
25053135
10.

Oncolytic polio virotherapy of cancer.

Brown MC, Dobrikova EY, Dobrikov MI, Walton RW, Gemberling SL, Nair SK, Desjardins A, Sampson JH, Friedman HS, Friedman AH, Tyler DS, Bigner DD, Gromeier M.

Cancer. 2014 Nov 1;120(21):3277-86. doi: 10.1002/cncr.28862. Epub 2014 Jun 17. Review.

PMID:
24939611
11.

Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas.

Zhang L, Chen LH, Wan H, Yang R, Wang Z, Feng J, Yang S, Jones S, Wang S, Zhou W, Zhu H, Killela PJ, Zhang J, Wu Z, Li G, Hao S, Wang Y, Webb JB, Friedman HS, Friedman AH, McLendon RE, He Y, Reitman ZJ, Bigner DD, Yan H.

Nat Genet. 2014 Jul;46(7):726-30. doi: 10.1038/ng.2995. Epub 2014 Jun 1.

12.

Personality and healthy sleep: the importance of conscientiousness and neuroticism.

Duggan KA, Friedman HS, McDevitt EA, Mednick SC.

PLoS One. 2014 Mar 20;9(3):e90628. doi: 10.1371/journal.pone.0090628. eCollection 2014.

13.

Childhood sleep duration and lifelong mortality risk.

Duggan KA, Reynolds CA, Kern ML, Friedman HS.

Health Psychol. 2014 Oct;33(10):1195-203. doi: 10.1037/hea0000078. Epub 2014 Mar 3.

14.

Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.

Affronti ML, Schneider SM, Herndon JE 2nd, Schlundt S, Friedman HS.

Support Care Cancer. 2014 Jul;22(7):1897-905. doi: 10.1007/s00520-014-2136-0. Epub 2014 Feb 26.

PMID:
24570103
15.

A retrospective analysis of clinical characteristics, hospitalization, and functional outcomes in residents with and without Clostridium difficile infection in US long-term care facilities.

Friedman HS, Navaratnam P, Reardon G, High KP, Strauss ME.

Curr Med Res Opin. 2014 Jun;30(6):1121-30. doi: 10.1185/03007995.2014.895311. Epub 2014 Mar 10.

PMID:
24552133
16.

Personality, well-being, and health.

Friedman HS, Kern ML.

Annu Rev Psychol. 2014;65:719-42. doi: 10.1146/annurev-psych-010213-115123. Review.

PMID:
24405364
17.

Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study.

Gururangan S, Fangusaro J, Poussaint TY, McLendon RE, Onar-Thomas A, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Fahey F, Vajapeyam S, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett JM, Fouladi M, Kun LE.

Neuro Oncol. 2014 Jan;16(2):310-7. doi: 10.1093/neuonc/not154. Epub 2013 Dec 4.

18.

Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework.

Stenberg K, Axelson H, Sheehan P, Anderson I, G├╝lmezoglu AM, Temmerman M, Mason E, Friedman HS, Bhutta ZA, Lawn JE, Sweeny K, Tulloch J, Hansen P, Chopra M, Gupta A, Vogel JP, Ostergren M, Rasmussen B, Levin C, Boyle C, Kuruvilla S, Koblinsky M, Walker N, de Francisco A, Novcic N, Presern C, Jamison D, Bustreo F; Study Group for the Global Investment Framework for Women's Children's Health.

Lancet. 2014 Apr 12;383(9925):1333-54. doi: 10.1016/S0140-6736(13)62231-X. Epub 2013 Nov 19.

PMID:
24263249
19.

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

Fangusaro J, Gururangan S, Poussaint TY, McLendon RE, Onar-Thomas A, Warren KE, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett JM, Kun LE, Fouladi M.

Cancer. 2013 Dec 1;119(23):4180-7. doi: 10.1002/cncr.28343. Epub 2013 Sep 19.

20.

Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.

Bota DA, Alexandru D, Keir ST, Bigner D, Vredenburgh J, Friedman HS.

J Neurosurg. 2013 Dec;119(6):1415-23. doi: 10.3171/2013.7.JNS1323. Epub 2013 Oct 4.

PMID:
24093630
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk